No association between the serotonin transporter promoter region (5-HTTLPR) and the dopamine D3 receptor (BalI D3DR) polymorphisms and heroin addiction.
Kotler
M
M
Cohen
H
H
Kremer
I
I
Mel
H
H
Horowitz
R
R
Ohel
N
N
Gritsenko
I
I
Nemanov
L
L
Katz
M
M
Ebstein
R
R
D002352:Carrier Proteins / Q000235:genetics*; D015252:Deoxyribonucleases, Type II Site-Specific; D005787:Gene Frequency; D005838:Genotype; D006556:Heroin Dependence / Q000235:genetics*; D006720:Homozygote; D006801:Humans; D007557:Israel; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics*; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins / Q000235:genetics; D011110:Polymorphism, Genetic; D012150:Polymorphism, Restriction Fragment Length; D011401:Promoter Regions, Genetic; D017448:Receptors, Dopamine D2 / Q000235:genetics*; D050637:Receptors, Dopamine D3; D012016:Reference Values; D050486:Serotonin Plasma Membrane Transport Proteins
D002352:Carrier Proteins; C493593:DRD3 protein, human; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D017448:Receptors, Dopamine D2; D050637:Receptors, Dopamine D3; C493230:SLC6A4 protein, human; D050486:Serotonin Plasma Membrane Transport Proteins; D015252:Deoxyribonucleases, Type II Site-Specific; C060616:TGGCCA-specific type II deoxyribonucleases